---
title: "Geron Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275604240.md"
datetime: "2026-02-11T12:27:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275604240.md)
  - [en](https://longbridge.com/en/news/275604240.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275604240.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275604240.md) | [繁體中文](https://longbridge.com/zh-HK/news/275604240.md)


# Geron Corporation to Announce Fourth Quarter and Full Year 2025 Financial Results

Geron Corporation announced it will release its fourth quarter and full year 2025 financial results and business highlights before the market opens on Wednesday, February 25, 2026. Results will be available on the Investors and Media section of the Company’s website. A conference call and webcast will be held at 8:00 a.m. Eastern Time, with a live and archived audio webcast accessible from the Investors and Media section of the Company’s website (here). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geron Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9652858-en) on February 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [Geron Corporation (GERN.US)](https://longbridge.com/en/quote/GERN.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/en/news/281174211.md)
- [Telomir seeks FDA approval for Telomir-1 to treat breast cancer](https://longbridge.com/en/news/281346305.md)
- [Telomir submits IND for Telomir-1 to treat advanced and metastatic TNBC](https://longbridge.com/en/news/281174396.md)
- [BUZZ-Tempus AI rises after study shows AI-driven alerts improve heart valve treatment](https://longbridge.com/en/news/281390073.md)
- [Cocrystal Pharma's CDI-988 Secures FDA Fast Track Designation To Prevent And Treat Norovirus](https://longbridge.com/en/news/281522861.md)